The role of glutamate in neuronal ischemic injury: the role of spark in fire.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 22044990)

Published in Neurol Sci on November 02, 2011

Authors

Botros B Kostandy1

Author Affiliations

1: Department of Pharmacology, Faculty of Medicine, University of Assiut, Assiut 71526, Egypt. botrosbk@hotmail.com

Articles citing this

Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci (2015) 0.93

Small molecule glutaminase inhibitors block glutamate release from stimulated microglia. Biochem Biophys Res Commun (2013) 0.88

Erythropoietin: powerful protection of ischemic and post-ischemic brain. Exp Biol Med (Maywood) (2014) 0.87

Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain. Biomolecules (2016) 0.86

Imaging increased glutamate in children with Sturge-Weber syndrome: Association with epilepsy severity. Epilepsy Res (2016) 0.86

Mechanisms of neurovascular dysfunction in acute ischemic brain. Curr Med Chem (2014) 0.85

Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice. J Mol Neurosci (2013) 0.85

Ischemia-like oxygen and glucose deprivation mediates down-regulation of cell surface γ-aminobutyric acidB receptors via the endoplasmic reticulum (ER) stress-induced transcription factor CCAAT/enhancer-binding protein (C/EBP)-homologous protein (CHOP). J Biol Chem (2014) 0.83

Low dose Hsp90 inhibitor 17AAG protects neural progenitor cells from ischemia induced death. J Cell Commun Signal (2014) 0.80

The properties, functions, and pathophysiology of maxi-anion channels. Pflugers Arch (2016) 0.79

Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke. Antioxid Redox Signal (2015) 0.79

Upregulation of protein phosphatase 2A and NR3A-pleiotropic effect of simvastatin on ischemic stroke rats. PLoS One (2012) 0.78

Buyang Huanwu decoction increases the expression of glutamate transporter-1 and glutamate synthetase in association with PACAP-38 following focal ischemia. Biomed Rep (2015) 0.77

Simvastatin reduces VEGF and NO levels in acute stages of experimental traumatic brain injury. Neurol Sci (2013) 0.77

Non-coding RNAs and neuroprotection after acute CNS injuries. Neurochem Int (2017) 0.76

Oxygen-Glucose Deprivation (OGD) Modulates the Unfolded Protein Response (UPR) and Inflicts Autophagy in a PC12 Hypoxia Cell Line Model. Cell Mol Neurobiol (2015) 0.76

Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy. Sci Rep (2016) 0.75

Raised Intracellular Calcium Contributes to Ischemia-Induced Depression of Evoked Synaptic Transmission. PLoS One (2016) 0.75

Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival. Sci Rep (2017) 0.75

Vectorized nanodelivery systems for ischemic stroke: a concept and a need. J Nanobiotechnology (2017) 0.75

Glutamate transporters in brain ischemia: to modulate or not? Acta Pharmacol Sin (2014) 0.75

The Effect of Noscapine on Oxygen-Glucose Deprivation on Primary Murine Cortical Neurons in High Glucose Condition. Iran J Pharm Res (2016) 0.75

The Edible Marine Alga Gracilariopsis chorda Alleviates Hypoxia/Reoxygenation-Induced Oxidative Stress in Cultured Hippocampal Neurons. J Med Food (2015) 0.75

Essential Roles of Natural Products and Gaseous Mediators on Neuronal Cell Death or Survival. Int J Mol Sci (2016) 0.75

Upregulation of glutamate metabolism by BYHWD in cultured astrocytes following oxygen-glucose deprivation/reoxygenation in part depends on the activation of p38 MAPK. Exp Ther Med (2017) 0.75

Articles cited by this

(truncated to the top 100)

Glutamate uptake. Prog Neurobiol (2001) 13.59

Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol (1997) 10.26

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70

The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem (2007) 4.75

Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A (2005) 4.63

Mitochondria and calcium: from cell signalling to cell death. J Physiol (2000) 3.73

Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron (2005) 3.72

Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem (1984) 3.39

Effect of anoxia on ion distribution in the brain. Physiol Rev (1985) 3.28

Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem (1999) 3.07

Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology (2008) 3.04

Glutamate neurotoxicity in cortical cell culture. J Neurosci (1987) 2.98

Calcium and neurodegeneration. Aging Cell (2007) 2.90

Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab (2006) 2.86

Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature (2000) 2.78

NMDA receptor subunit-dependent [Ca2+] signaling in individual hippocampal dendritic spines. J Neurosci (2005) 2.65

PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem (1999) 2.42

Calcium, ischemia and excitotoxicity. Cell Calcium (2010) 2.38

Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem (2006) 2.27

Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg (1981) 2.23

Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci (2005) 2.16

Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A (2001) 2.16

Roles and rules of kainate receptors in synaptic transmission. Nat Rev Neurosci (2003) 2.11

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11

Oxidative stress in brain ischemia. Brain Pathol (1999) 2.02

NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res (2006) 1.93

Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke (1998) 1.82

Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev (2004) 1.81

The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol (2005) 1.81

Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res (1999) 1.80

Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene (1998) 1.79

Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J Cell Sci (2002) 1.79

Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem (2000) 1.77

Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol (2007) 1.75

Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci (1996) 1.73

Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci (2001) 1.72

Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J Biol Chem (1998) 1.72

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res (1988) 1.71

Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology (2008) 1.70

The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol (1957) 1.67

The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg (2009) 1.64

PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci (2007) 1.62

Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron (2007) 1.61

Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci (2010) 1.60

Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem (1987) 1.58

Presynaptic Ca2+ channels: a functional patchwork. Trends Neurosci (2003) 1.57

Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol (2002) 1.57

Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem (2003) 1.55

Excitotoxicity and the NMDA receptor--still lethal after eight years. Trends Neurosci (1995) 1.51

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46

Hydrogen peroxide stimulates the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. J Biol Chem (1995) 1.46

Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res (2007) 1.44

Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci U S A (1997) 1.44

Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell Mol Life Sci (2005) 1.41

Regulation of AMPA receptors and synaptic plasticity. Neuroscience (2008) 1.39

Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis (2010) 1.39

Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci (2002) 1.37

Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem (2003) 1.37

Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci U S A (2002) 1.36

Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.35

Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke (2008) 1.32

Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury. Exp Neurol (2009) 1.31

Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res (2000) 1.31

A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci (2006) 1.31

Activation of the Na+/H+ antiporter during cell volume regulation. Evidence for a phosphorylation-independent mechanism. J Biol Chem (1992) 1.29

Intracellular calcium activates TRPM2 and its alternative spliced isoforms. Proc Natl Acad Sci U S A (2009) 1.28

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem (1988) 1.28

Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta (2009) 1.27

The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J Bioenerg Biomembr (2004) 1.27

Postsynaptic mechanisms of excitotoxicity: Involvement of postsynaptic density proteins, radicals, and oxidant molecules. Neuroscience (2008) 1.24

Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci (2009) 1.22

Zinc-containing neurons. Biol Signals (1995) 1.22

Glutamate release and neuronal damage in ischemia. Life Sci (2001) 1.22

The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci (1997) 1.17

The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med (2004) 1.16

Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis (2005) 1.16

Zinc: new clues to diverse roles in brain ischemia. Trends Pharmacol Sci (2011) 1.13

New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem Res (2007) 1.10

Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage. BMC Neurosci (2010) 1.10

Free radicals and myocardial ischemia. The role of xanthine oxidase. Adv Myocardiol (1985) 1.10

Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis. Nat Neurosci (2005) 1.09

Ischaemic brain damage: the role of excitatory activity and of calcium entry. Br J Anaesth (1985) 1.08

Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res (2001) 1.06

Blockade of microglial glutamate release protects against ischemic brain injury. Exp Neurol (2008) 1.06

Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics (2009) 1.05

Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br J Pharmacol (1998) 1.04

Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system. J Child Neurol (2004) 1.04

Drugs acting on calcium channels: potential treatment for ischaemic stroke. Br J Clin Pharmacol (1992) 1.02

Biology of ischemic cerebral cell death. Prog Cardiovasc Dis (1999) 1.02

Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease. Neurology (2008) 1.01

Reassessment of the Ca2+ sensing property of a type I metabotropic glutamate receptor by simultaneous measurement of inositol 1,4,5-trisphosphate and Ca2+ in single cells. J Biol Chem (2001) 1.01

Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep (2003) 1.01

Real-time visualization of cytoplasmic calpain activation and calcium deregulation in acute glutamate excitotoxicity. J Neurochem (2009) 1.00

Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death. Proc Natl Acad Sci U S A (2002) 0.98

The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J Neurotrauma (2005) 0.98

Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci (2005) 0.98

Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J Biol Chem (2004) 0.97

Ischemic preconditioning: a novel target for neuroprotective therapy. Cerebrovasc Dis (2006) 0.96

The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J Cereb Blood Flow Metab (2007) 0.96

Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc Brain Metab Rev (1995) 0.95